
Pharmaceutical Lipids Market Size, Share & Trend Analysis, By Product, By Chemical Source, By Source, By Composition, By Application, By Route of Administration, Regional Stance, Competitive Tactics, and Segment Forecast to 2030
Healthcare & Life Sciences
PDF,PPT
Reports and Insights
379
June 2022
Recent
Pharmaceutical Lipids Market Overview
The report is titled as ‘Pharmaceutical Lipids Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Pharmaceutical Lipids market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
The pharmaceutical lipids market is estimated to reach at a value of US$ 5,740.4 Mn by the end of 2022 and expected to reach at a value of US$ 10,306.1 Mn by 2030 with a significant CAGR of 7.6%.
Pharmaceutical Lipids Overview
Lipids can be understood as organic compounds that comprise carbon, hydrogen, and oxygen atoms, which makes the composition for the design and function of living cells. These organic compounds are basically nonpolar molecules, which can get dissolved only in nonpolar solvents and are insoluble in water as water is a polar molecule. In the human body, these molecules can be synthesized in the liver and are found in butter, oil, cheese, whole milk, fried foods as well as in certain red meats. In the pharmaceutical industry, polymers and lipids are believed as pillar excipients for the composition of different drugs. For instance, the pharmaceutical lipids are employed as solubilizers, stabilizers, transfection agents, permeation enhancers, and many more.
Notably, the pharmaceutical lipids have brief toxicity and have the potential to achieve an enormous fusion of action that paves its way to improved drug delivery. Owing to which, the pharmaceutical lipids witness huge demand all across the global markets and thus estimating rapid market growth in the following years.
In addition to that, the soaring applications of pharmaceutical lipids in various chronic health issues including neurological diseases, cancer, cardiovascular diseases, and other serious ailments is further projected to offer major breakthroughs to the growth of the global pharmaceutical lipids market over the coming years.
Key Takeaways from the Market Study
- The pharmaceutical lipids market is estimated to reach at a value of US$ 5,740.4 Mn by the end of 2022 and expected to reach at a value of US$ 10,306.1 Mn by 2030 with a significant CAGR of 7.6%.
- The simple lipids product type segment in pharmaceutical lipids market is expected to create an incremental opportunity of US$ 2,832.5 Mn during the forecast period
- In 2022, the compound lipid chemical source segment accounted for the largest market share and expected to grow at 7.7% CAGR during the forecast period.
- In 2022, conventional lipid-based drug delivery systems application segment accounted for a key market share and expected to grow at 7.5% CAGR during the forecast period.
- North America region is expected to remain one of the key market throughout the forecast period (2022-2030) and is further anticipated to witness a significant growth in the pharmaceutical industry.
- In terms of value, parental route of administration segment is expected to account more than one third of the market share in 2022
Significant growth in the demand for medicine to alter the growth outlook
Presently, medicine demand is increasing all over the globe, due to growing number of oncological diseases, chronic diseases, and growing awareness for well-being and OTC medicines. Further increase in the incidences for several diseases results in higher demand for medicine intake. The economic and social value of treatments and medications for chronic disease will rise as the prevalence for chronic disease like diabetes is growing, and the pharmaceutical companies are also focusing on volume sales of such medicine and in developing countries these medicines are available at lower prices to reach out maximum customers. Global significant demand for the medicine is fuelling up the consumption for pharmaceutical lipids including liposomal drugs such as for cancer treatment, it is projected that drug manufacturing companies will need to increase their production capacities. Pharmaceutical excipients are expected to aid pharmaceutical lipids achieve better functionalities like longer self-life and also render competitive advantage in formulations.
Pharmaceutical Lipids Market Segmentation
The global pharmaceutical lipids market is segmented on the basis of product, chemical sources, sources, composition, application, route of administration, and region.
By Product
Simple Lipids
Triglycerides
Waxes
Compound Lipids
Phospholipids
Sphignolipids
Glycolipds
Supholipds
Derived Lipids
Steroids
Sterol sulfates
Prostaglandins
Others
Cholesterol
Fatty Acids
Others
By Chemical Sources
Compound Lipids
1,2-Dimyristoyl-sn-glycero-3-phosphate (DMPA)
1,2-Dipalmitoyl-sn-glycero-3-phosphate (DPPA)
1,2-Distearoyl-sn-glycero-3-phosphate (DSPA)
1,2-Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG)
1,2-Dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG)
1,2-Distearoyl-sn-glycero-3-phosphoglycerol (DSPG)
1,Palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)
Others
Derived Lipids
Carotenoids
Retinol
Tocopherols
PGA2
PGB2
PGE2
PGF1α
Others
Others
By Source
Synthetic
Semi-Synthetic
Natural
By Composition
Simple Lipids
Compound Lipids
Derived Lipids
By Application
Conventional Lipid-based Drug Delivery Systems
Self-Emulsifying Drug Delivery Systems
Self-Microemulsifying Drug Delivery Systems
Liposomes
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Others
By Route of Administration
Tablet
Solution
Parenteral
Intravenous
Intramuscular (Vaccines)
Topical
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Pharmaceutical Lipids Market Key Players
Some of the key participating players in global pharmaceutical lipids market are:
ABITEC Corporation (ABF Ingredients)
BASF SE
Croda International Plc
CordenPharma
NOF (Nippon Oil & Fats) Corporation
Cayman Chemical Company
Lipoid GmbH
Nippon Fine Chemical Co. Ltd.
Dishman Group
Gattefossé
IOI Oleo GmbH
Stepan Company
Evonik Industries AG
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
Global Economic Growth Outlook
Healthcare Infrastructure Sector Growth Outlook
Top Companies Historical Growth Rate
Impact of Pricing
Growing Demand for Medicine
Growing Investment in Research and Development
Biotechnology industry growth outlook
New Drug Class Development
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.